Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Schizophrenia

Free Subscription 14.01.2019 1 Am J Psychiatry 1 J Abnorm Psychol 5 J Clin Psychopharmacol 3 Mol Psychiatry 1 Neuropsychopharmacology 1 PLoS One 7 Psychiatry Res 2 Psychol Med 4 Schizophr Res 1 Trends Neurosci

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am J Psychiatry

1. ESCOTT-PRICE V, Pardinas AF, Santiago E, Walters J, et al
   The Relationship Between Common Variant Schizophrenia Liability and Number of Offspring in the UK Biobank.
   Am J Psychiatry. 2019 Jan 4:appiajp201818020140.
   PubMed     Text format     Abstract available
   
   

   
   J Abnorm Psychol

2. CHUN CA, Ciceron L, Kwapil TR
   A meta-analysis of context integration deficits across the schizotypy spectrum using AX-CPT and DPX tasks.
   J Abnorm Psychol. 2018;127:789-806.
   PubMed     Text format     Abstract available
   
   

   
   J Clin Psychopharmacol

3. DYKEMA LR
   Abrupt Improvement in Obsessive-Compulsive Symptoms Upon Discontinuation of Clozapine.
   J Clin Psychopharmacol. 2018;38:88-89.
   PubMed     Text format    
   
   
4. SAVULICH G, Mezquida G, Atkinson S, Bernardo M, et al
   A Case Study of Clozapine and Cognition: Friend or Foe?
   J Clin Psychopharmacol. 2018;38:152-153.
   PubMed     Text format    
   
   
5. HELLAND A, Habib S, Ulvestad L, Spigset O, et al
   Systemic Inflammation Complicates the Interpretation of Therapeutic Drug Monitoring of Risperidone.
   J Clin Psychopharmacol. 2018;38:263-265.
   PubMed     Text format    
   
   
6. GONZALEZ-RODRIGUEZ A, Estrada F, Monreal JA, Palao D, et al
   A Systematic Review of Methods for the Measurement of Antipsychotic Adherence in Delusional Disorder.
   J Clin Psychopharmacol. 2018;38:412-414.
   PubMed     Text format    
   
   
7. DIEFENDERFER LA, Lang SE, Patel M
   Successful Treatment of Delusional Disorder With Aripiprazole Long-Acting Injection.
   J Clin Psychopharmacol. 2018;38:400-402.
   PubMed     Text format    
   
   

   
   Mol Psychiatry

8. AMARE AT, Vaez A, Hsu YH, Direk N, et al
   Bivariate genome-wide association analyses of the broad depression phenotype combined with major depressive disorder, bipolar disorder or schizophrenia reveal eight novel genetic loci for depression.
   Mol Psychiatry. 2019 Jan 9. pii: 10.1038/s41380-018-0336.
   PubMed     Text format     Abstract available
   
   
9. ESCOTT-PRICE V, Bracher-Smith M, Menzies G, Walters J, et al
   Genetic liability to schizophrenia is negatively associated with educational attainment in UK Biobank.
   Mol Psychiatry. 2019 Jan 4. pii: 10.1038/s41380-018-0328.
   PubMed     Text format    
   
   
10. SMELAND OB, Bahrami S, Frei O, Shadrin A, et al
    Genome-wide analysis reveals extensive genetic overlap between schizophrenia, bipolar disorder, and intelligence.
    Mol Psychiatry. 2019 Jan 4. pii: 10.1038/s41380-018-0332.
    PubMed     Text format     Abstract available
    
    

    
    Neuropsychopharmacology

11. DAVIES C, Paloyelis Y, Rutigliano G, Cappucciati M, et al
    Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis.
    Neuropsychopharmacology. 2019 Jan 9. pii: 10.1038/s41386-018-0311.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

12. O'NEILL B, Kalia S, Aliarzadeh B, Moineddin R, et al
    Agreement between primary care and hospital diagnosis of schizophrenia and bipolar disorder: A cross-sectional, observational study using record linkage.
    PLoS One. 2019;14:e0210214.
    PubMed     Text format     Abstract available
    
    

    
    Psychiatry Res

13. CHAN CC, Shanahan M, Ospina LH, Larsen EM, et al
    Premorbid adjustment trajectories in schizophrenia and bipolar disorder: A transdiagnostic cluster analysis.
    Psychiatry Res. 2018;272:655-662.
    PubMed     Text format     Abstract available
    
    
14. BYRNE M, Codjoe L, Morgan C, Stahl D, et al
    The relationship between ethnicity and service access, treatment uptake and the incidence of psychosis among people at ultra high risk for psychosis.
    Psychiatry Res. 2018;272:618-627.
    PubMed     Text format     Abstract available
    
    
15. KURTZ MM, Gopal S, John S, Thara R, et al
    Objective psychosocial function vs. subjective quality-of-life in schizophrenia within 5-years after diagnosis: A study from southern India.
    Psychiatry Res. 2018;272:419-424.
    PubMed     Text format     Abstract available
    
    
16. YANG H, Jiang Y, Chen Z, Wu J, et al
    A study of anti-gliadin antibodies in first-episode patients with schizophrenia among a Chinese population.
    Psychiatry Res. 2018;272:454-457.
    PubMed     Text format     Abstract available
    
    
17. KOZLOWSKA E, Agier J, Wysokinski A, Lucka A, et al
    The expression of toll-like receptors in peripheral blood mononuclear cells is altered in schizophrenia.
    Psychiatry Res. 2018;272:540-550.
    PubMed     Text format     Abstract available
    
    
18. LAMPROPOULOS D, Fonte D, Apostolidis T
    Exploring the link between stigma and social representations among people with and without schizophrenia in the French context.
    Psychiatry Res. 2018;272:595-601.
    PubMed     Text format     Abstract available
    
    
19. LI MZ, Chen LC, Rong H, Xu SX, et al
    Low-charge electrotherapy for patients with schizophrenia: A double-blind, randomised controlled pilot clinical trial.
    Psychiatry Res. 2018;272:676-681.
    PubMed     Text format     Abstract available
    
    

    
    Psychol Med

20. NUECHTERLEIN KH, Subotnik KL, Ventura J, Turner LR, et al
    Enhancing return to work or school after a first episode of schizophrenia: the UCLA RCT of Individual Placement and Support and Workplace Fundamentals Module training.
    Psychol Med. 2019 Jan 4:1-9. doi: 10.1017/S0033291718003860.
    PubMed     Text format     Abstract available
    
    
21. PEH OH, Rapisarda A, Lee J
    Childhood adversities in people at ultra-high risk (UHR) for psychosis: a systematic review and meta-analysis.
    Psychol Med. 2019 Jan 8:1-13. doi: 10.1017/S003329171800394.
    PubMed     Text format     Abstract available
    
    

    
    Schizophr Res

22. JOHN J, Kukshal P, Bhatia T, Nimgaonkar VL, et al
    Rare variant based evidence for oligogenic contribution of neurodevelopmental pathway genes to schizophrenia.
    Schizophr Res. 2019 Jan 3. pii: S0920-9964(18)30741.
    PubMed     Text format    
    
    
23. ANDERSON-SCHMIDT H, Gade K, Malzahn D, Papiol S, et al
    The influence of religious activity and polygenic schizophrenia risk on religious delusions in schizophrenia.
    Schizophr Res. 2019 Jan 3. pii: S0920-9964(18)30721.
    PubMed     Text format     Abstract available
    
    
24. KLINE ER
    Commentary: Unmet need for mental health services among people screened but not admitted to an early psychosis intervention program.
    Schizophr Res. 2019 Jan 2. pii: S0920-9964(18)30745.
    PubMed     Text format    
    
    
25. MALMQVIST A, Schwieler L, Orhan F, Fatouros-Bergman H, et al
    Increased peripheral levels of TARC/CCL17 in first episode psychosis patients.
    Schizophr Res. 2019 Jan 3. pii: S0920-9964(18)30729.
    PubMed     Text format     Abstract available
    
    

    
    Trends Neurosci

26. MCCUTCHEON RA, Abi-Dargham A, Howes OD
    Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms.
    Trends Neurosci. 2019 Jan 6. pii: S0166-2236(18)30317.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: